We are live on ! Find out more
Pictet Asset Management

Pictet Asset Management Portfolio holdings

AUM $105B
1-Year Est. Return 38.07%
This Fund
S&P 500
This Quarter Est. Return
-2.91%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
10 Year Est. Return
AUM
$81.1B
AUM Growth
Cap. Flow
+$84.5B
Cap. Flow %
104.29%
Top 10 Hldgs %
15.07%
Holding
1,945
New
1,945
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.9B
2
AAPL icon
Apple
AAPL
+$1.68B
3
TMO icon
Thermo Fisher Scientific
TMO
+$1.34B
4
SNPS icon
Synopsys
SNPS
+$1.29B
5
NVDA icon
NVIDIA
NVDA
+$1.24B

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Healthcare 16%
3 Industrials 15.5%
4 Consumer Discretionary 8.77%
5 Utilities 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTYX
351
DELISTED
Ventyx Biosciences
VTYX
$33.7M 0.04%
+969,979
New +$33.5M
SHW icon
352
Sherwin-Williams
SHW
$88.5B
$33.5M 0.04%
+131,359
New +$35.2M
BDX icon
353
Becton Dickinson
BDX
$49.4B
$33.4M 0.04%
+129,210
New +$34.9M
MO icon
354
Altria Group
MO
$109B
$33.1M 0.04%
+787,521
New +$34.8M
BX icon
355
Blackstone
BX
$110B
$32.7M 0.04%
+305,584
New +$31.8M
SBAC icon
356
SBA Communications
SBAC
$19.3B
$32M 0.04%
+159,849
New +$35.6M
MDB icon
357
MongoDB
MDB
$35.3B
$31.5M 0.04%
+91,042
New +$34.6M
IOVA icon
358
Iovance Biotherapeutics
IOVA
$2.94B
$31.5M 0.04%
+6,913,684
New +$45.1M
EQR icon
359
Equity Residential
EQR
$24.4B
$31.2M 0.04%
+531,961
New +$34.4M
BRKR icon
360
Bruker
BRKR
$8.69B
$31M 0.04%
+498,322
New +$33.5M
RARE icon
361
Ultragenyx Pharmaceutical
RARE
$2.66B
$31M 0.04%
+869,388
New +$34.4M
MLTX icon
362
MoonLake Immunotherapeutics
MLTX
$1.41B
$30.9M 0.04%
+541,901
New +$29.9M
EFOR
363
Everforth Inc
EFOR
$1.35B
$30.7M 0.04%
+376,394
New +$30M
ENB icon
364
Enbridge
ENB
$113B
$30.6M 0.04%
+918,531
New +$32.6M
ORLY icon
365
O'Reilly Automotive
ORLY
$74.9B
$30.4M 0.04%
+502,125
New +$31.5M
FAF icon
366
First American
FAF
$7.32B
$30.3M 0.04%
+537,193
New +$32.2M
BCRX icon
367
BioCryst Pharmaceuticals
BCRX
$2.64B
$29.7M 0.04%
+4,192,300
New +$30.1M
NTLA icon
368
Intellia Therapeutics
NTLA
$1.68B
$29.6M 0.04%
+937,317
New +$36.4M
YUMC icon
369
Yum China
YUMC
$16.3B
$29.5M 0.04%
+528,943
New +$29.6M
PSX icon
370
Phillips 66
PSX
$89.5B
$29.4M 0.04%
+244,512
New +$27.4M
MCO icon
371
Moody's
MCO
$82.5B
$29.2M 0.04%
+92,496
New +$31.5M
VLO icon
372
Valero Energy
VLO
$93.3B
$29.2M 0.04%
+206,202
New +$27M
HUBS icon
373
HubSpot
HUBS
$11B
$28.9M 0.04%
+58,760
New +$30.7M
EMR icon
374
Emerson Electric
EMR
$91.7B
$28.9M 0.04%
+299,233
New +$28.5M
GPOR icon
375
Gulfport Energy Corp
GPOR
$3.03B
$28.8M 0.04%
+242,782
New +$26.9M

Similar funds

Pictet Asset Management's Q3 2023 Portfolio in Review

Q3 2023 is the first quarter with a 13F filing on record for Pictet Asset Management, which disclosed 1,945 positions worth $81.1B. Its ten largest holdings account for 15% of the portfolio.

Its largest position is Microsoft: 5,754,059 shares worth $1.82B.

By sector, the portfolio is most concentrated in Technology at 29% of assets, followed by Healthcare and Industrials.

  • Pictet Asset Management's largest Q3 2023 buy was Microsoft: 5,754,059 shares worth $1.82B.
  • Pictet Asset Management's ten largest holdings make up 15% of its $81.1B portfolio in Q3 2023.
  • Pictet Asset Management disclosed 1,945 positions in Q3 2023, its first 13F filing on record.

Based on Pictet Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.